Glibenclamide manufacturers

Filters

Filters

Filters , active

Country of origin : India
None products found

glibenclamide

Tablets 5 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
Myanmar, South Africa, Sri Lanka
Manufacturer #23786
Founded in the 1950s with nearly seven decades of pharmaceutical leadership, this integrated pharma company is among the top players in its home market. Rx and OTC portfolio spans branded generics, biosimilars, APIs, and novel drugs across oncology, metabolic, cardiac, and infectious disease therapy areas. US FDA and EU-GMP approved facilities operate across multiple continents.

glibenclamide

Tablets 5 mg, 10 mg

Dossier type
US CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
FDA
Manufacturer #19316
This pharmaceutical company specializes in both over-the-counter (OTC) and prescription generic drugs, offering products in the form of tablets, capsules, and liquids. Founded in 1992, they initially focused on the US market before expanding globally. They hold a significant distinction as the first Indian company to receive USFDA approvals for producing both OTC and prescription drugs for the US market. Their manufacturing facility is located in India, with a dedicated marketing and distribution center in the USA. Key therapy areas are not specified, nor are details about specific product patents or GMP certifications provided.

glibenclamide

Tablets 5 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP
Manufacturer #2303
A pharmaceutical manufacturer with over 25 years of experience that develops and produces fixed-dose and single-entity generic and specialty pharmaceutical products. The company offers an extensive range of injectable dosage forms, including parenterals, and also manufactures oral solids. Its facilities operate under recognised international quality certifications such as EU-GMP, ANVISA, PIC/S and TGA approvals, supporting reliable large-scale production of pharmaceutical products for global export while emphasizing efficacy, affordability and consistent quality.

Want to see all products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Glibenclamide:

Glibenclamide, or also known as glyburide, is a drug used for the effective treatment of type 2 diabetes. It was developed in the 1960s during a cooperative study between the two companies Boehringer Mannheim (now Roche) and Hoechst (now Sanofi-Aventis). Following appraisal, it was approved for medical use in the United States in 1984. Glibenclamide can now be distributed in a cost effective manner as a generic medication in line with other pharmaceutical products which have had their patent expire. As such, it is offered for both sale and wholesale at various price points and under different brand names, including Gliben-J, Daonil, Diabeta, Euglucon, Gilemal, Glidanil, Glybovin, Glynase, Maninil, Micronase and Semi-Daonil. Additionally, glibenclamide manufacturers commonly list it as a combination drug with metformin. Which is sold under brand names, including Bagomet Plus, Benimet, Glibomet, Gluconorm, Glucored, Glucovance, Metglib, and others.

Method of action of glibenclamide:

Glibenclamide belongs to a group of drugs called sulfonylureas which treat type 2 diabetes by augmenting the secretion of insulin in pancreatic beta cells. This is facilitated by the inhibition of regulatory subunits causing cell membrane depolarization, allowing calcium access intracellularly and subsequent stimulation of insulin release. With insulin being the hormone responsible for the regulation of blood sugar by promoting the absorption of glucose from the blood into the liver, fat, and skeletal muscle cells. Conferring effective treatment of type 2 diabetes and associated symptoms such as excessive thirst, dysuria, and lethargies.

Glibenclamide containment and dosage:

Glibenclamide manufacturers and glibenclamide suppliers package the medication in tablet, capsule, or oral suspension form. With one 5mg tablet or capsule typically being prescribed to be taken once a day with breakfast or immediately after. This dose can be adjusted by a medical professional up to a recommended two 15mg doses twice a day. It is best taken alongside participation in exercise and at a consistent time. Liquid suspensions are predominantly used for the treatment of infants, with the dosage adjusted to match.

Glibenclamide on Pipelinepharma:

Due to the generic nature, there exists a wide variety of glibenclamide suppliers, distributors, and manufacturers on the market offering their product for wholesale. Searching on our company Pipelinepharma.com online marketplace currently reveals 28 verified global B2B providers located in countries, including India, Mexico, Turkey, the European Union, Israel, Ukraine, Brazil, Switzerland, Jordan, China, South Korea, Egypt, Argentina, Russian, Kuwait, and Oman. These are trusted manufacturers and distributors which have been verified according to strict quality control by the Pipelinepharma team.

Price of glibenclamide and how to buy:

As with other products, the cost of purchase remains confidential and negotiable online between both B2B parties. However, in certain cases, the manufacturer or wholesaler may have chosen to include a desired price to facilitate an order, if so, this indicated cost per sample will be visible in the Pipelinepharma.com list. As such, this enables a clear route for a buyer looking to source glibenclamide or any other pharmaceutical products from an array of global trusted manufacturers and distributors.

Willing to unlock more features?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible

Want unlimited access to the Pipelinepharma database?

Become a subscriber to unlock:

  • Streamlined product sourcing: access the only CTD dossier pipeline and sourcing platform.

  • Direct connections: communicate directly with CTD dossier owners and manufacturers with no brokerage fees.

  • Higher profitability: compare multiple supplier offers and secure the best commercial terms.

  • Expanded network: view supplier portfolios and stay updated on new products.

  • Value-added product ideas: discover products with lower competition potential.

  • Access to marketing authorizations for sale: find already registered products in your target markets.